$SIBN
SI-BONE Inc

2020 Q4 Form 10-Q Financial Statement

#000145983920000099 Filed on November 03, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $22.14M $20.37M $16.18M
YoY Change 11.76% 25.9% 20.93%
Cost Of Revenue $2.280M $2.578M $1.630M
YoY Change 11.22% 58.16% 33.5%
Gross Profit $19.87M $17.80M $14.55M
YoY Change 11.82% 22.29% 19.67%
Gross Profit Margin 89.75% 87.35% 89.93%
Selling, General & Admin $25.31M $23.69M $23.26M
YoY Change 3.43% 1.86% 68.17%
% of Gross Profit 127.38% 133.14% 159.83%
Research & Development $2.430M $2.778M $1.874M
YoY Change 36.52% 48.24% 36.49%
% of Gross Profit 12.23% 15.61% 12.88%
Depreciation & Amortization $340.0K $300.0K $200.0K
YoY Change 70.0% 50.0% 0.0%
% of Gross Profit 1.71% 1.69% 1.37%
Operating Expenses $27.74M $26.47M $25.13M
YoY Change 5.68% 5.32% 65.31%
Operating Profit -$7.870M -$8.675M -$10.58M
YoY Change -7.19% -18.01% 247.6%
Interest Expense -$1.010M $1.102M $1.243M
YoY Change 36.49% -11.34% -3.04%
% of Operating Profit
Other Income/Expense, Net -$100.0K $111.0K -$94.00K
YoY Change -176.92% -218.09% -82.43%
Pretax Income -$8.980M -$9.470M -$11.31M
YoY Change -1.32% -16.27% 136.12%
Income Tax
% Of Pretax Income
Net Earnings -$8.980M -$9.474M -$11.31M
YoY Change -1.32% -16.2% 135.93%
Net Earnings / Revenue -40.56% -46.5% -69.87%
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share -$282.7K -$0.33 -$456.0K
COMMON SHARES
Basic Shares Outstanding 32.36M shares 28.71M shares 24.80M shares
Diluted Shares Outstanding 28.71M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $196.4M $132.0M $96.22M
YoY Change 114.02% 37.2% 587.31%
Cash & Equivalents $53.58M $56.00M $12.61M
Short-Term Investments $142.9M $76.02M $83.61M
Other Short-Term Assets $2.600M $1.000M $1.600M
YoY Change 4.0% -37.5% 128.57%
Inventory $5.633M $5.071M $4.953M
Prepaid Expenses
Receivables $13.61M $11.42M $9.918M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $218.2M $149.5M $112.7M
YoY Change 95.8% 32.66% 353.37%
LONG-TERM ASSETS
Property, Plant & Equipment $4.527M $4.479M $3.025M
YoY Change 14.49% 48.07% 47.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $5.300M
YoY Change -100.0% -100.0%
Other Assets $374.0K $314.0K $305.0K
YoY Change 18.73% 2.95% -79.48%
Total Long-Term Assets $4.901M $4.793M $8.603M
YoY Change -11.65% -44.29% 143.44%
TOTAL ASSETS
Total Short-Term Assets $218.2M $149.5M $112.7M
Total Long-Term Assets $4.901M $4.793M $8.603M
Total Assets $223.1M $154.3M $121.3M
YoY Change 90.7% 27.2% 327.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.271M $3.102M $2.623M
YoY Change 16.36% 18.26% 46.54%
Accrued Expenses $10.20M $8.719M $10.21M
YoY Change -12.12% -14.61% 42.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $13.47M $11.82M $12.83M
YoY Change -28.25% -7.89% 43.52%
LONG-TERM LIABILITIES
Long-Term Debt $39.46M $39.37M $39.16M
YoY Change 13.17% 0.54% 0.67%
Other Long-Term Liabilities $854.0K $1.095M $363.0K
YoY Change 135.91% 201.65% 9.34%
Total Long-Term Liabilities $40.31M $40.46M $39.52M
YoY Change 14.43% 2.38% 0.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.47M $11.82M $12.83M
Total Long-Term Liabilities $40.31M $40.46M $39.52M
Total Liabilities $53.78M $52.28M $52.36M
YoY Change -0.41% -0.14% 6.25%
SHAREHOLDERS EQUITY
Retained Earnings -$239.3M -$230.3M -$186.5M
YoY Change 22.34% 23.5% 22.77%
Common Stock $3.000K $3.000K $3.000K
YoY Change 0.0% 0.0% 200.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $169.4M $102.0M $68.96M
YoY Change
Total Liabilities & Shareholders Equity $223.1M $154.3M $121.3M
YoY Change 90.7% 27.2% 327.24%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$8.980M -$9.474M -$11.31M
YoY Change -1.32% -16.2% 135.93%
Depreciation, Depletion And Amortization $340.0K $300.0K $200.0K
YoY Change 70.0% 50.0% 0.0%
Cash From Operating Activities -$7.880M -$5.550M -$7.120M
YoY Change -12.83% -22.05% 181.42%
INVESTING ACTIVITIES
Capital Expenditures -$820.0K -$480.0K -$750.0K
YoY Change 1.23% -36.0% 1150.0%
Acquisitions
YoY Change
Other Investing Activities -$67.01M -$4.670M $8.480M
YoY Change -1150.31% -155.07%
Cash From Investing Activities -$67.82M -$5.160M $7.730M
YoY Change -1317.59% -166.75% -12983.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 73.04M 460.0K 580.0K
YoY Change 5743.2% -20.69% 38.1%
NET CHANGE
Cash From Operating Activities -7.880M -5.550M -7.120M
Cash From Investing Activities -67.82M -5.160M 7.730M
Cash From Financing Activities 73.04M 460.0K 580.0K
Net Change In Cash -2.660M -10.25M 1.190M
YoY Change 19.82% -961.34% -154.84%
FREE CASH FLOW
Cash From Operating Activities -$7.880M -$5.550M -$7.120M
Capital Expenditures -$820.0K -$480.0K -$750.0K
Free Cash Flow -$7.060M -$5.070M -$6.370M
YoY Change -14.22% -20.41% 157.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001459839
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38701
dei Entity Registrant Name
EntityRegistrantName
SI-BONE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2216351
dei Entity Address Address Line1
EntityAddressAddressLine1
471 El Camino Real
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Clara
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95050
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
207-0700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
SIBN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32360839 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55996000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10435000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76024000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
81345000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
263000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
238000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11417000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
11720000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
5071000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
5452000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1014000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2510000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
149522000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
111462000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1278000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4479000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3954000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
314000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
315000 USD
CY2020Q3 us-gaap Assets
Assets
154315000 USD
CY2019Q4 us-gaap Assets
Assets
117009000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3102000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2811000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8719000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11605000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4358000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11821000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18774000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39368000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
34865000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1095000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
362000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
52284000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
54001000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
430000 USD
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28838577 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28838577 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25163803 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25163803 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
331896000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
258121000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
464000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-230298000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-195580000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
102031000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
63008000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
154315000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117009000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20373000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16182000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51243000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47490000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2578000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1630000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6627000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4744000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
17795000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
14552000 USD
us-gaap Gross Profit
GrossProfit
44616000 USD
us-gaap Gross Profit
GrossProfit
42746000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18772000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16443000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
53808000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
48985000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2778000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1874000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7033000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5503000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4920000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6816000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14471000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15776000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
26470000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
25133000 USD
us-gaap Operating Expenses
OperatingExpenses
75312000 USD
us-gaap Operating Expenses
OperatingExpenses
70264000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8675000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10581000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-30696000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27518000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
192000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
612000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1019000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2051000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1102000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
1243000 USD
us-gaap Interest Expense
InterestExpense
5016000 USD
us-gaap Interest Expense
InterestExpense
3706000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
111000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-94000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9474000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34718000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29305000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-33000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-11000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-37000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-11000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
47000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9654000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11347000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34752000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29269000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28713418 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24803452 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28155561 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24596788 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
63008000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
62978000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
174000 USD
CY2020Q1 sibn Stock Issued During Period Amount Restricted Stock Units
StockIssuedDuringPeriodAmountRestrictedStockUnits
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2622000 USD
CY2020Q1 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
27000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12000 USD
CY2020Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
221000 USD
CY2020Q2 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
26000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-12772000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
116270000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
185000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
991000 USD
CY2020Q2 sibn Stock Issued During Period Amount Restricted Stock Units
StockIssuedDuringPeriodAmountRestrictedStockUnits
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2955000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-85000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-12472000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
107868000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
628000 USD
CY2020Q3 sibn Stock Issued During Period Amount Restricted Stock Units
StockIssuedDuringPeriodAmountRestrictedStockUnits
0 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3180000 USD
CY2020Q3 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
9000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-33000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9474000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
102031000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
90192000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
125000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1871000 USD
CY2019Q1 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
66000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
160000 USD
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-19000 USD
CY2019Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
25000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9345000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
82755000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
442000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1263000 USD
CY2019Q2 sibn Stock Issued During Period Amount Restricted Stock Units
StockIssuedDuringPeriodAmountRestrictedStockUnits
0 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1814000 USD
CY2019Q2 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
56000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12000 USD
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
59000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-8654000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
77747000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
611000 USD
CY2019Q3 sibn Stock Issued During Period Amount Restricted Stock Units
StockIssuedDuringPeriodAmountRestrictedStockUnits
0 USD
CY2019Q3 sibn Stock Repurchased During Period Originally Issued For Exercise Of Unvested Stock Options Value
StockRepurchasedDuringPeriodOriginallyIssuedForExerciseOfUnvestedStockOptionsValue
0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1911000 USD
CY2019Q3 sibn Adjustments To Additional Paid In Capital Share Based Compensation Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationVestingOfEarlyExercisedStockOptions
39000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-37000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11306000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
68961000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34718000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29305000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8757000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
5596000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
786000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
570000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
235000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
16000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1288000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
43000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
204000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
194000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1534000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-248000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-152000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-63000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1383000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-337000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1575000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1489000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-394000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
416000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
526000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2072000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3525000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22780000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22594000 USD
sibn Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
63200000 USD
sibn Proceeds From Maturity Of Marketable Securities
ProceedsFromMaturityOfMarketableSecurities
117100000 USD
sibn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
12592000 USD
sibn Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
69145000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
107545000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
45297000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1744000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1639000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4903000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7916000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
62978000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
45297000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
750000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
843000 USD
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
991000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1263000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
987000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1178000 USD
sibn Payments For Repurchase Of Unvested Early Exercised Stock Options
PaymentsForRepurchaseOfUnvestedEarlyExercisedStockOptions
0 USD
sibn Payments For Repurchase Of Unvested Early Exercised Stock Options
PaymentsForRepurchaseOfUnvestedEarlyExercisedStockOptions
38000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
167000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63363000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2236000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-64000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45561000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12506000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10435000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25120000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55996000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12614000 USD
sibn Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
62000 USD
sibn Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
161000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
256000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
31000 USD
us-gaap Nature Of Operations
NatureOfOperations
The Company and Nature of Business<div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SI-BONE, Inc. (the “Company”) was incorporated in the state of Delaware on March 18, 2008 and is headquartered in Santa Clara, California. The Company is a medical device company that has pioneered a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of the most common types of sacroiliac joint disorders that cause lower back pain. The Company introduced its primary product, the iFuse Implant System, or iFuse, in 2009 in the U.S., in 2010 in certain countries in the European Union, and in 2015 in certain countries in the rest of the world.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company completed its initial public offering (“IPO”), by issuing 8,280,000 shares of common stock, at an offering price of $15.00 per share, for net proceeds of $113.4 million after deducting underwriting discounts and commissions and offering costs. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company received $50.3 million of net proceeds, after deducting the underwriting discounts and commissions, from its first follow-on public offering of 4,300,000 shares of the Company's common stock at a public offering price of $21.50 per share, of which 2,490,053 shares were offered and sold by the Company. Further, in February 2020, the underwriters fully exercised their option to purchase 645,000 shares of the Company's common stock at a public offering price of $21.50 per share for an additional net proceeds of $13.0 million to the Company, after deducting underwriting discounts and commissions. The total public offering costs incurred in connection with the follow-on offering were allocated based on the gross proceeds received by the Company and the other selling shareholders on a pro-rated basis. Public offering cost of $0.4 million allocated to selling of shares by the Company was charged against the gross proceeds received from the follow-on offering. Public offering costs of $0.2 million allocated to selling of shares by the selling shareholders was recognized as transaction costs within general and administrative expenses on the unaudited condensed consolidated statements of operations in the first quarter of 2020.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received $71.9 million of net proceeds, after deducting the underwriting discounts and commissions, from its second follow-on public offering. See Note 12 - Subsequent Events of Notes to Condensed Consolidated Financial Statements for related discussions.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience, where applicable and other assumptions believed to be reasonable by the management. Actual results could differ from those estimates.
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20373000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16182000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
51243000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47490000 USD
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
52290000 USD
CY2020Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
52290000 USD
CY2020Q3 sibn Available For Sale Debt Securities Current Amortized Cost Basis
AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
75981000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
300000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000 USD
CY2020Q3 sibn Marketable Securities Accumulated Gross Unrealized Gain Before Tax
MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
43000 USD
CY2020Q3 sibn Available For Sale Debt Securities Current Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
43000 USD
CY2020Q3 sibn Available For Sale Debt Securities Current Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76024000 USD
CY2020Q3 sibn Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
128271000 USD
CY2020Q3 sibn Marketable Securities Accumulated Gross Unrealized Loss Before Tax
MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 sibn Marketable Securities Fair Value
MarketableSecuritiesFairValue
128314000 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5563000 USD
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5563000 USD
CY2019Q4 sibn Available For Sale Debt Securities Current Amortized Cost Basis
AvailableForSaleDebtSecuritiesCurrentAmortizedCostBasis
81291000 USD
CY2019Q4 sibn Available For Sale Debt Securities Current Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedGainBeforeTax
58000 USD
CY2019Q4 sibn Available For Sale Debt Securities Current Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesCurrentAccumulatedGrossUnrealizedLossBeforeTax
4000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
81345000 USD
CY2019Q4 sibn Available For Sale Debt Securities Noncurrent Amortized Cost Basis
AvailableForSaleDebtSecuritiesNoncurrentAmortizedCostBasis
1278000 USD
CY2019Q4 sibn Available For Sale Debt Securities Noncurrent Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesNoncurrentAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2019Q4 sibn Available For Sale Debt Securities Noncurrent Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesNoncurrentAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1278000 USD
CY2019Q4 sibn Marketable Securities Amortized Cost
MarketableSecuritiesAmortizedCost
88132000 USD
CY2019Q4 sibn Marketable Securities Accumulated Gross Unrealized Gain Before Tax
MarketableSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
58000 USD
CY2019Q4 sibn Marketable Securities Accumulated Gross Unrealized Loss Before Tax
MarketableSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000 USD
CY2019Q4 sibn Marketable Securities Fair Value
MarketableSecuritiesFairValue
88186000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9060000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7749000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4581000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3795000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4479000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3954000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
200000 USD
us-gaap Depreciation
Depreciation
800000 USD
us-gaap Depreciation
Depreciation
600000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7754000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7274000 USD
CY2020Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2019Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
3200000 USD
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
377000 USD
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
392000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
588000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
739000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8719000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11605000 USD
CY2020Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
CY2019Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
282000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1042000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
963000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
875000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
875000 USD
CY2020Q3 sibn Operating Leases Future Minimum Payments Due After Year Four
OperatingLeasesFutureMinimumPaymentsDueAfterYearFour
364000 USD
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4401000 USD
CY2020Q3 us-gaap Purchase Obligation
PurchaseObligation
400000 USD
CY2019Q4 us-gaap Purchase Obligation
PurchaseObligation
400000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
41000000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
40000000 USD
CY2020Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
699000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
777000 USD
CY2020Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
933000 USD
CY2019Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
0 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
39368000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
39223000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4358000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39368000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
34865000 USD
CY2020Q3 sibn Write Off Of Deferred Debt Issuance Cost And Debt Discount
WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount
700000 USD
sibn Write Off Of Deferred Debt Issuance Cost And Debt Discount
WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount
700000 USD
sibn Prepayment Penalty And Lender Fees In Extinguishment Of Debt
PrepaymentPenaltyAndLenderFeesInExtinguishmentOfDebt
800000 USD
CY2020Q3 sibn Share Based Compensation Arrangement By Share Based Payment Award Options Early Exercise Common Stock Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
7784 shares
CY2020Q3 sibn Prepayment Penalty And Lender Fees In Extinguishment Of Debt
PrepaymentPenaltyAndLenderFeesInExtinguishmentOfDebt
800000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
11667000 USD
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20000000 USD
CY2020Q3 sibn Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
9333000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
41000000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2718971 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
26236 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.02
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.31
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
227334 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
13524 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
17.21
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2504349 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.40
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3700000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.43
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.78
CY2019Q4 sibn Share Based Compensation Arrangement By Share Based Payment Award Options Early Exercise Common Stock Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEarlyExerciseCommonStockSubjectToRepurchase
21404 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
74685 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
99086 shares
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1000000.0 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1300000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3180000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1911000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8757000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5596000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9474000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-11306000 USD
us-gaap Net Income Loss
NetIncomeLoss
-34718000 USD
us-gaap Net Income Loss
NetIncomeLoss
-29305000 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28713418 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24803452 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28155561 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24596788 shares
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3609984 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4019378 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4019378 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3609984 shares

Files In Submission

Name View Source Status
0001459839-20-000099-index-headers.html Edgar Link pending
0001459839-20-000099-index.html Edgar Link pending
0001459839-20-000099.txt Edgar Link pending
0001459839-20-000099-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sibn-20200930.htm Edgar Link pending
sibn-20200930.xsd Edgar Link pending
sibn-20200930_cal.xml Edgar Link unprocessable
sibn-20200930_def.xml Edgar Link unprocessable
sibn-20200930_htm.xml Edgar Link completed
sibn-20200930_lab.xml Edgar Link unprocessable
sibn-20200930_pre.xml Edgar Link unprocessable
sibn-ex311930202010xq.htm Edgar Link pending
sibn-ex312930202010xq.htm Edgar Link pending
sibn-ex321930202010xq.htm Edgar Link pending